Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYSABRI vs UBLITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TYSABRI vs UBLITUXIMAB: Safety Overview

Metric TYSABRI UBLITUXIMAB
Total FAERS Reports 8,210 1,582
Deaths Reported 156 27
Death Rate 1.9% 1.7%
Hospitalizations 1,256 213
Average Patient Age 46.4 yrs 49.7 yrs
% Female Patients N/A 73.4%
Manufacturer N/A TG Therapeutics, Inc.
Route N/A INTRAVENOUS